Federica Frezzato (Livio Trentin)

Scopus Author ID ResearcherID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Tyrosine Kinase

Chronic Lymphocytic Leukemia

Top Venues

British journal of haematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Francesco Angotzi, Ivan Zatta, Federica Frezzato, Laura Bonaldi, Annalisa Martines, Stefano Pravato, Francesco Piazza, Livio Trentin, Andrea Visentin
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens. British journal of haematology 205 (1) (2024)
Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco, Francesco Angotzi, Ivan Zatta, Federica Frezzato, Laura Bonaldi, Annalisa Martines, Stefano Pravato, Francesco Piazza, Livio Trentin, Andrea Visentin
Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax-based regimens. British journal of haematology (2024)
Nayla Mouawad, Edoardo Ruggeri, Guido Capasso, Leonardo Martinello, Andrea Visentin, Francesco Angotzi, Federica Frezzato
How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia. Hematological oncology 42 (2) (2024)
Nayla Mouawad, Edoardo Ruggeri, Guido Capasso, Leonardo Martinello, Andrea Visentin, Francesco Angotzi, Federica Frezzato
How receptor tyrosine kinase-like orphan receptor 1 meets its partners in chronic lymphocytic leukemia. Hematological oncology 42 (2) (2024)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Filippo Severin, Nayla Mouawad, Edoardo Ruggeri, Andrea Visentin, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Stefano Pravato, Francesco Angotzi, Monica Facco, Livio Trentin, Federica Frezzato
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness. British journal of haematology (2023)
Nayla Mouawad, Guido Capasso, Edoardo Ruggeri, Leonardo Martinello, Filippo Severin, Andrea Visentin, Monica Facco, Livio Trentin, Federica Frezzato
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? Biomolecules 13 (4) (2023)
Mario Angelo Pagano, Federica Frezzato, Andrea Visentin, Livio Trentin, Anna Maria Brunati
Protein Phosphorylation and Redox Status: An as Yet Elusive Dyad in Chronic Lymphocytic Leukemia. Cancers 14 (19) (2022)
Federica Frezzato, Andrea Visentin, Filippo Severin, Serena Pizzo, Edoardo Ruggeri, Nayla Mouawad, Leonardo Martinello, Elisa Pagnin, Valentina Trimarco, Alessia Tonini, Samuela Carraro, Stefano Pravato, Silvia Imbergamo, Sabrina Manni, Francesco A Piazza, Anna Maria Brunati, Monica Facco, Livio Trentin
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers 13 (21) (2021)
Andrea Visentin, Federica Frezzato, Filippo Severin, Silvia Imbergamo, Stefano Pravato, Leila Romano Gargarella, Sabrina Manni, Serena Pizzo, Edoardo Ruggeri, Monica Facco, Anna Maria Brunati, Gianpietro Semenzato, Francesco A Piazza, Livio Trentin
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia. OncoTargets and therapy 13 (2020)
Federica Frezzato, Flavia Raggi, Veronica Martini, Filippo Severin, Valentina Trimarco, Andrea Visentin, Edoardo Scomazzon, Benedetta Accordi, Silvia Bresolin, Francesco Piazza, Monica Facco, Giuseppe Basso, Gianpietro Semenzato, Livio Trentin
HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia. International journal of cancer 145 (11) (2019)
Mario Angelo Pagano, Elena Tibaldi, Pierfrancesco Molino, Federica Frezzato, Valentina Trimarco, Monica Facco, Giuseppe Zagotto, Giovanni Ribaudo, Luigi Leanza, Roberta Peruzzo, Ildikò Szabò, Andrea Visentin, Martina Frasson, Gianpietro Semenzato, Livio Trentin, Anna Maria Brunati
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL. Leukemia 33 (5) (2018)
Andrea Visentin, Silvia Imbergamo, Edoardo Scomazzon, Stefano Pravato, Federica Frezzato, Laura Bonaldi, Marco Pizzi, Stefania Vio, Michele Gregianin, Marta Burei, Monica Facco, Gianpietro Semenzato, Francesco Piazza, Livio Trentin
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome. British journal of haematology 185 (1) (2018)
Laura Patrussi, Nagaja Capitani, Francesca Cattaneo, Noemi Manganaro, Alessandra Gamberucci, Federica Frezzato, Veronica Martini, Andrea Visentin, Pier Giuseppe Pelicci, Mario M D'Elios, Livio Trentin, Gianpietro Semenzato, Cosima T Baldari
p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes. Oncogene 37 (11) (2018)
Veronica Martini, Cristina Gattazzo, Federica Frezzato, Valentina Trimarco, Marco Pizzi, Giorgia Chiodin, Filippo Severin, Edoardo Scomazzon, Vincenza Guzzardo, Deborah Saraggi, Flavia Raggi, Leonardo Martinello, Monica Facco, Andrea Visentin, Francesco Piazza, Anna Maria Brunati, Gianpietro Semenzato, Livio Trentin
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. British journal of haematology 178 (1) (2017)
Andrea Visentin, Chiara Briani, Silvia Imbergamo, Federica Frezzato, Annalisa Angelini, Marny Fedrigo, Mario Cacciavillani, Sara Altinier, Francesco Piazza, Gianpietro Semenzato, Fausto Adami, Livio Trentin
Idelalisib plus rituximab is effective in systemic AL amyloidosis secondary to chronic lymphocytic leukaemia. Hematological oncology 36 (1) (2017)